Diamel therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, and hyperandrogenaemia (Q36072462)

12 August 2017

Diamel therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, and hyperandrogenaemia (English)

1 reference

polycystic ovary syndrome

12 August 2017

1 reference

1 reference

1 reference

Arturo Hernández-Yero

1

1 reference

12 August 2017

Felipe Santana Pérez

2

1 reference

12 August 2017

Gisel Ovies Carballo

3

1 reference

12 August 2017

Eduardo Cabrera-Rode

4

1 reference

12 August 2017

21 June 2012

1 reference

International journal of endocrinology

12 August 2017

1 reference

12 August 2017

2012

1 reference

12 August 2017

382719

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Metformin reduces abortion in pregnant women with polycystic ovary syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Use and abuse of HOMA modeling

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

The pathophysiology of polycystic ovary syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Insulin resistance in polycystic ovary syndrome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Tissue insulin sensitivity and body weight in polycystic ovary syndrome

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F382719

Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F382719

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F382719

Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F382719

Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F382719

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388435

Revised concept for the estimation of insulin sensitivity from a single sample

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22778733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2012/382719

1 reference

12 August 2017

1 reference

12 August 2017

1 reference